BioSpace News Archive

Allogene Therapeutics, Inc. today announced the closing of its previously announced initial public offering of 20,700,000 shares of its common stock, which includes 2,700,000 shares sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares, at a price to the public of $18.00 per share

Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on the Department of Health and Human Services’ proposal requiring drug companies to disclose the list price of prescription drugs in television ads:

Twelve Central Texas residents in their sixties have been chosen to be featured on the exclusive Austin 60 Strong 2019 calendar that highlights events and activities around Austin, and serves as a roadmap to good health

Weleda announces a new partnership with The Foundation for Living Beauty, a nonprofit organization supporting women with cancer.

FH Collins III, DDS and his team at Collins Dental in Winter Springs are preparing to host their sixth annual Smiles From The Heart event, which provides FREE dental care to members of the community who may have fallen on hard times.

LOS ANGELES, /PRNewswire/ -- Turn Therapeutics, formerly Global Health Solutions, a noted innovator in chronic wound care and skin disease, has announced positive in-vivo data for its herpes zoster opthalmicus (shingles of the eye) drug candidate.

Using Global Handwashing Day (October 15) as Platform to Kick Off Program, Free Instruction Kits Now Available to Teachers, School Administrators

Today, two Illinois-based nonprofit risk pools, who provide more than 203 local municipalities and other public entities with cost-effective workers’ compensation and employee healthcare insurance, filed a joint lawsuit in the Circuit Court of Cook County against leading opioid manufacturers, distributors, professional associations, and prescribers.

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it will report third quarter financial results after the Nasdaq market closes on Monday, Nov. 5, 2018.

Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the third quarter 2018 after market close on Monday, November 5, 2018 at 5:00 PM Eastern Time.